Join us at Discovery US and network with us and over 350 industry leaders. We will be there to discuss the latest advancements in ultra-High Throughput Screening, Mass Spectrometry, target identification, validation and HIT optimisation.
The 2-day programme addresses drug discovery in new modalities such as protein degradation, and case studies on the integration of screening approaches in phenotypic and genomics-based discovery, Organ-on-a-chip and 3D modelling
Click here for more information about the conference.
Friday November 18th
Keynote 2: 09:50-10:20 AM
Fleur Kleinpenning, PhD
“Label-free ultra-High Throughput Screening platform: De-risked hit finding and orthogonal triaging through mass spectrometry”.
Will you meet us there? Schedule your appointment with our experts here directly!
